Xanax Addiction Treatment in Norwood, Bergen County, NJ

Alprazolam withdrawal is among the most medically dangerous of any substance — more so than opioid withdrawal in terms of acute mortality risk. Because Xanax has a 6–12 hour half-life, GABA receptor sensitization is maximal and rebound can produce grand mal seizures, status epilepticus, and delirium within 24–48 hours of the last dose. Unlike opioid withdrawal, which is intensely uncomfortable but rarely fatal in otherwise healthy adults, untreated benzodiazepine withdrawal can kill. Valley Spring Recovery Center coordinates with medical detox facilities when the dose history or taper complexity warrants inpatient monitoring before beginning outpatient programming.

The detox decision for Xanax depends on the daily dose in milligrams, how long the drug has been taken, and whether other CNS depressants — alcohol or opioids — are involved. Clients taking more than 4 mg daily for longer than six months, or those with any prior seizure history on discontinuation, are typically referred to a partner inpatient detox facility before entering Valley Spring's PC. The clinical team's psychiatric evaluation within 24 hours of first contact determines the appropriate entry point; some clients can begin a medically managed outpatient taper with close monitoring, while others need the safety of inpatient withdrawal first.

Yes — and that retraining is a primary goal of Xanax-specific care at Valley Spring Recovery Center. The taper protocol reduces alprazolam dose gradually, usually crossing over first to diazepam (Valium) to smooth out the short half-life peaks and troughs, while the psychiatric provider concurrently introduces non-addictive anxiety medications: SSRIs such as escitalopram, SNRIs such as venlafaxine, or buspirone. Simultaneously, the CBT program directly targets the avoidance behaviors and catastrophic thinking patterns that make panic feel unmanageable without sedation — building real tolerance to anxiety through exposure-based work rather than chemical suppression.

The outpatient clinical program itself — PC at 4–6 weeks followed by IOP at 6–8 weeks — is measurable, but the alprazolam taper running alongside it is not. For high-dose, long-duration users, a safe diazepam crossover taper may take three to six months to complete; attempting to compress that timeline increases seizure risk. Clients who came off Xanax through a medically supervised taper and completed the outpatient program typically continue in outpatient individual therapy until the anxiety management skills are fully consolidated and the non-benzodiazepine medication regimen is stable.